
CAS 72542-49-5
:Formula:C27H44O2
InChI:InChI=1S/C27H44O2/c1-17(6-11-24-25(2,3)29-24)21-9-10-22-20-8-7-18-16-19(28)12-14-26(18,4)23(20)13-15-27(21,22)5/h7,17,19-24,28H,6,8-16H2,1-5H3/t17-,19+,20+,21-,22+,23+,24-,26+,27-/m1/s1
InChI key:OSENKJZWYQXHBN-PJXSLZQESA-N
SMILES:C[C@H](CC[C@@H]1C(O1)(C)C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 5 prodotti.
(3S,8S,9S,10R,13R,14S,17R)-17-((R)-4-((R)-3,3-Dimethyloxiran-2-yl)butan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
CAS:Formula:C27H44O2Peso molecolare:400.637124,25-Epoxycholesterol
CAS:24,25-Epoxycholesterol is an oxysterol agonist of the liver X receptor, known to inhibit the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) in hepatic cells. Additionally, 24,25-Epoxycholesterol plays a role in regulating cholesterol metabolism within the liver.Formula:C27H44O2Colore e forma:SolidPeso molecolare:400.64Ref: 4Z-C-5334
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta24,25-Epoxycholesterol
CAS:Prodotto controllatoFormula:C27H44O2Colore e forma:NeatPeso molecolare:400.63724,25-Epoxycholesterol
CAS:Prodotto controllato24,25-Epoxycholesterol is a type of oxysterol that binds to the benzoyl group of benzoates. It is also known as an inhibitor of cholesterol synthesis. 24,25-Epoxycholesterol has been shown to bind to human liver cells with high affinity and inhibit cholesterol synthesis. This compound has also been shown to increase vitamin D levels by inhibiting the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3. This inhibition leads to increased availability of vitamin D in the body due to decreased degradation. As a result, 24,25-epoxycholesterol may be useful in pharmacological treatments for diseases such as atherosclerosis and diabetes mellitus type II.Formula:C27H44O2Purezza:Min. 95%Peso molecolare:400.6 g/mol





